Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C / 대한간학회지
The Korean Journal of Hepatology
; : 187-191, 2010.
Article
de Ko
| WPRIM
| ID: wpr-14480
Bibliothèque responsable:
WPRO
ABSTRACT
Combined pegylated interferon and ribavirin therapy for chronic hepatitis C infection cause a wide range of side effects, including flu-like syndrome, hematological abnormalities, cardiovascular symptoms, gastrointestinal symptoms, pulmonary dysfunction, depression, and retinopathy. Interferon-alpha has been shown to be related to the development of various autoimmune diseases, including systemic lupus erythematosus, rheumatoid arthritis, autoimmune thyroid disease, and type 1 diabetes mellitus (DM). Type 1 DM and thyroid disease respectively develop in 0.08~2.61% and 10~15% of patients treated with combined interferon-alpha and ribavirin for chronic hepatitis C. The coexistence of type 1 DM and autoimmune thyroiditis was rarely reported. We report a case of a 33-year-old female patient with chronic hepatitis C who simultaneously developed diabetic ketoacidosis and autoimmune thyroiditis after treatment with pegylated interferon-alpha 2b and ribavirin.
Mots clés
Texte intégral:
1
Indice:
WPRIM
Sujet Principal:
Antiviraux
/
Polyéthylène glycols
/
Ribavirine
/
Thyroxine
/
Thyroïdite auto-immune
/
Interféron alpha
/
Acidocétose diabétique
/
Hépatite C chronique
/
Association de médicaments
/
Insuline
Limites du sujet:
Adult
/
Female
/
Humans
langue:
Ko
Texte intégral:
The Korean Journal of Hepatology
Année:
2010
Type:
Article